Agios Pharmaceuticals (AGIO) closed the last trading session at $32.80, gaining 10.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

Investors in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) had a good week, as its shares rose 9.7% to close at US$34.54 ...

Q1 2024 Earnings Call Transcript May 2, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge ...

In a nutshell, Agios Pharmaceuticals Inc (AGIO) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that ...

Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $81.5 million in its first quarter. The Cambridge, Massachusetts-based company said it had a loss of $1.45 per share. The results ...

Good morning, and welcome to Agios’ First Quarter 2024 Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded at Agios’ request. I would now ...

AGIO stock results show that Agios Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for ...

Agios Pharmaceuticals (AGIO) came out with a quarterly loss of $1.45 per share versus the Zacks Consensus Estimate of a loss of $1.64. This compares to loss of $1.47 per share a year ago.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stay Updated with Latest Share Market News, Share Market Live Updates, Sensex Today, Nifty Live, IPO News, BSE/NSE News, Mutual Funds and Commodity Market News Updates on Business Standard.